Study sheds new light on p53 tumor suppressor gene’s role in ulcerative colitis

Researchers in the lab of Michael Sigal at the Max Delbrück Center and Charité – Universitätsmedizin Berlin have elucidated the role of the p53 gene in ulcerative colitis.

Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic

Scribe Therapeutics, a biotech co-founded by CRISPR pioneer Jennifer Doudna, is reducing its workforce by about 20%, the company confirmed to Endpoints News. CEO Ben

January 9, 2025

Cannabis Stocks Are Wasting Their Time Listing in Canada

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter

October 16, 2023

Latest data of InnoCare’s ICP-332 for the Treatment of Atopic Dermatitis Presented at LBA Session of 2024 AAD – Biotech Investments

EQS Newswire / 11/03/2024 / 09:00 UTC+8 Latest data of InnoCare’s ICP-332 for the Treatment of Atopic Dermatitis Presented at LBA Session of 2024

March 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.